查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378928

COVID-19 诊断市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022 年，全球 COVID-19 诊断市场规模达到 744 亿美元。展望未来， IMARC Group预计到 2028 年该市场将达到 273 亿美元。

COVID-19 诊断是指为检测个体是否有病毒感染而进行的临床测试。 COVID-19 是由新发现的人畜共通冠状病毒引起的传染病。一些常见症状包括发烧、疲劳、干咳、气短、喉咙痛和身体疼痛。病毒感染通常透过逆转录酶聚合酶链反应（RT-PCR）、抗原检测和抗体检测来诊断。这些测试使用试剂和试剂盒从鼻咽 (NP)、口咽 (OP) 和鼻拭子、人类唾液或血液中获取样本。它们广泛应用于医院、实验室、诊所、研究所和诊断中心。

冠状病毒疾病的突然爆发和全球范围内 COVID-19 病例数量的惊人增加是创造市场成长积极前景的关键因素之一。每日病例数的持续上升导致广泛采用诊断测试来进行快速和全面的检测，以便为患者提供早期治疗。与此一致的是，对大规模检测和分子诊断的需求不断增长，推动了市场的成长。此外，各种产品创新，例如用于家庭检测的新型抗体和血清学检测试剂盒的推出，也是其他成长诱导因素。与传统使用的测试套件相比，这些变体耗时更少，并且可以与基于软体的程式整合以获得准确的结果。其他因素，包括实施有利的政府政策以防止 COVID-19 感染进一步传播，以及医疗基础设施的显着改善，尤其是在发展中经济体，预计将推动市场成长。

本报告回答的关键问题

  • 2022 年全球 COVID-19 诊断市场规模有多大？
  • COVID-19 对全球 COVID-19 诊断市场有何影响？
  • 推动全球 COVID-19 诊断市场的关键因素是什么？
  • 根据产品类型，全球 COVID-19 诊断市场的细分如何？
  • 根据样本类型，全球 COVID-19 诊断市场的细分如何？
  • 根据测试类型，全球 COVID-19 诊断市场的细分如何？
  • 根据模式，全球 COVID-19 诊断市场的细分如何？
  • 根据最终用途，全球 COVID-19 诊断市场的细分如何？
  • 全球 COVID-19 诊断市场的关键地区有哪些？
  • 全球 COVID-19 诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球 COVID-19 诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 试剂和试剂盒
    • 市场趋势与预测
  • 仪器
    • 市场趋势与预测
  • 其他的
    • 市场趋势与预测

第 7 章：依样本类型分類的市场区隔

  • 鼻咽拭子
    • 市场趋势与预测
  • 口咽拭子
    • 市场趋势与预测
  • 鼻拭子
    • 市场趋势与预测
  • 血
    • 市场趋势与预测
  • 其他的
    • 市场趋势与预测

第 8 章：按测试类型分類的市场

  • 分子 (RT-PCR) 检测
    • 市场趋势与预测
  • 基于抗原的测试
    • 市场趋势与预测
  • 抗体（血清学）测试
    • 市场趋势与预测
  • 其他的
    • 市场趋势与预测

第 9 章：按模式分類的市场区隔

  • 即时护理 (PoC)
    • 市场趋势与预测
  • 非即时照护 (Non-PoC)
    • 市场趋势与预测

第 10 章：依最终用途分類的市场细分

  • 实验室
    • 市场趋势与预测
  • 医院
    • 市场趋势与预测
  • 诊断中心和诊所
    • 市场趋势与预测
  • 其他的
    • 市场趋势与预测

第 11 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场趋势与预测
    • 加拿大
      • 市场趋势与预测
  • 亚太
    • 中国
      • 市场趋势与预测
    • 日本
      • 市场趋势与预测
    • 印度
      • 市场趋势与预测
    • 韩国
      • 市场趋势与预测
    • 澳洲
      • 市场趋势与预测
    • 印尼
      • 市场趋势与预测
    • 其他的
      • 市场趋势与预测
  • 欧洲
    • 德国
      • 市场趋势与预测
    • 法国
      • 市场趋势与预测
    • 英国
      • 市场趋势与预测
    • 义大利
      • 市场趋势与预测
    • 西班牙
      • 市场趋势与预测
    • 俄罗斯
      • 市场趋势与预测
    • 其他的
      • 市场趋势与预测
  • 拉丁美洲
    • 巴西
      • 市场趋势与预测
    • 墨西哥
      • 市场趋势与预测
    • 其他的
      • 市场趋势与预测
  • 中东和非洲
    • 市场趋势与预测
    • 按国家/地区分類的市场细分

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Danaher Corporation
    • F. Hoffman-La Roche Ltd. (Roche Holding AG)
    • Luminex Corporation
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Robert Bosch GmbH
    • Seegene Inc.
    • Siemens Aktiengesellschaft
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A3552

Abstract

The global COVID-19 diagnostics market size reached US$ 74.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.3 Billion by 2028.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global COVID-19 diagnostics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, sample type, test type, mode and end use.

Breakup by Product Type:

Reagents and Kits

Instruments

Others

Breakup by Sample Type:

Nasopharyngeal Swabs

Oropharyngeal Swabs

Nasal Swabs

Blood

Others

Breakup by Test Type:

Molecular (RT-PCR) Testing

Antigen-based Testing

Antibody (Serology) Testing

Others

Breakup by Mode:

Point-of-Care (PoC)

Non-Point-of-Care (Non-PoC)

Breakup by End Use:

Laboratories

Hospitals

Diagnostic Centers and Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global COVID-19 diagnostics market in 2022?
  • 2. What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
  • 3. What are the key factors driving the global COVID-19 diagnostics market?
  • 4. What is the breakup of the global COVID-19 diagnostics market based on the product type?
  • 5. What is the breakup of the global COVID-19 diagnostics market based on the sample type?
  • 6. What is the breakup of the global COVID-19 diagnostics market based on the test type?
  • 7. What is the breakup of the global COVID-19 diagnostics market based on the mode?
  • 8. What is the breakup of the global COVID-19 diagnostics market based on the end use?
  • 9. What are the key regions in the global COVID-19 diagnostics market?
  • 10. Who are the key players/companies in the global COVID-19 diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COVID-19 Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends and Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends and Forecast
  • 6.3 Others
    • 6.3.1 Market Trends and Forecast

7 Market Breakup by Sample Type

  • 7.1 Nasopharyngeal Swabs
    • 7.1.1 Market Trends and Forecast
  • 7.2 Oropharyngeal Swabs
    • 7.2.1 Market Trends and Forecast
  • 7.3 Nasal Swabs
    • 7.3.1 Market Trends and Forecast
  • 7.4 Blood
    • 7.4.1 Market Trends and Forecast
  • 7.5 Others
    • 7.5.1 Market Trends and Forecast

8 Market Breakup by Test Type

  • 8.1 Molecular (RT-PCR) Testing
    • 8.1.1 Market Trends and Forecast
  • 8.2 Antigen-based Testing
    • 8.2.1 Market Trends and Forecast
  • 8.3 Antibody (Serology) Testing
    • 8.3.1 Market Trends and Forecast
  • 8.4 Others
    • 8.4.1 Market Trends and Forecast

9 Market Breakup by Mode

  • 9.1 Point-of-Care (PoC)
    • 9.1.1 Market Trends and Forecast
  • 9.2 Non-Point-of-Care (Non-PoC)
    • 9.2.1 Market Trends and Forecast

10 Market Breakup by End Use

  • 10.1 Laboratories
    • 10.1.1 Market Trends and Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends and Forecast
  • 10.3 Diagnostic Centers and Clinics
    • 10.3.1 Market Trends and Forecast
  • 10.4 Others
    • 10.4.1 Market Trends and Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends and Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends and Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends and Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends and Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends and Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends and Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends and Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends and Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends and Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends and Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends and Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends and Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends and Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends and Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends and Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends and Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends and Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends and Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends and Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends and Forecast
    • 11.5.2 Market Breakup by Country

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Luminex Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics Incorporated
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Robert Bosch GmbH
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Seegene Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Siemens Aktiengesellschaft
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2022-2028
  • Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2022
  • Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2022
  • Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2022
  • Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2022-2028
  • Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2022-2028
  • Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2022-2028
  • Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2022-2028
  • Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2022-2028
  • Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million US$), 2022-2028
  • Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million US$), 2022-2028
  • Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million US$), 2022-2028
  • Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2022-2028
  • Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2022-2028
  • Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2022-2028
  • Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2022-2028
  • Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
  • Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
  • Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2023-2028
  • Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2023-2028
  • Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
  • Table 9: Global: COVID-19 Diagnostics Market: Key Players